Lista de obras -

Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future.

artículo científico publicado en 2015

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2017

Bioavailability of voriconazole in hospitalised patients.

artículo científico publicado en 2016

Clarithromycin significantly increases linezolid serum concentrations

artículo científico publicado en 2010

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents

artículo científico publicado en 2009

Clinical validation of the analysis of fluconazole in oral fluid in hospitalized children

artículo científico publicado en 2014

Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic

artículo científico publicado en 2020

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients

artículo científico publicado en 2010

Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

artículo científico publicado en 2016

Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry

artículo científico publicado en 2015

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

scientific article published on 17 May 2019

Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill

artículo científico publicado en 2022

Dosing ethambutol in obese patients.

artículo científico publicado en 2010

Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.

artículo científico publicado en 2013

Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones

artículo científico publicado en 2016

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for

scientific article published on 25 June 2020

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2012

Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis

artículo científico

Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review

scientific article published on 07 January 2020

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting.

artículo científico publicado en 2017

Ganciclovir Therapeutic Drug Monitoring: A Case Series

artículo científico publicado en 2019

Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.

artículo científico publicado en 2015

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

artículo científico publicado en 2016

Inflammation is associated with voriconazole trough concentrations.

artículo científico publicado en 2014

Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children

artículo científico publicado en 2014

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis

artículo científico publicado en 2010

Limited-sampling strategies for anidulafungin in critically ill patients

artículo científico publicado en 2014

Low Caspofungin Exposure in Patients in Intensive Care Units.

artículo científico publicado en 2016

Low but sufficient anidulafungin exposure in critically ill patients

artículo científico publicado en 2013

Membrane Filtration Is Suitable for Reliable Elimination of Mycobacterium tuberculosis from Saliva for Therapeutic Drug Monitoring

artículo científico publicado en 2017

Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework

artículo científico publicado en 2020

Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy

artículo científico publicado en 2016

Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis

artículo científico publicado en 2015

Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2020

Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams

artículo científico publicado en 2011

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.

artículo científico publicado en 2016

Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients

artículo científico publicado en 2017

Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage

artículo científico publicado en 2009

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis

scientific article published in 2022

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations

artículo científico publicado en 2019

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2014

Precision Therapy for Invasive Fungal Diseases

scientific article published in 2021

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

artículo científico publicado en 2016

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

scientific article published on 16 June 2020

Quantification of co-trimoxazole in serum and plasma using MS/MS.

artículo científico publicado en 2015

Risk factors contributing to a low darunavir plasma concentration.

artículo científico publicado en 2017

Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.

artículo científico publicado en 2015

Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis

artículo científico publicado en 2017

Statin Adjunctive Therapy for Tuberculosis Treatment

artículo científico publicado en 2016

Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing

artículo científico publicado en 2017

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

artículo científico publicado en 2019

Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis

artículo científico publicado en 2016

The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.

artículo científico publicado en 2018

The effect of inflammation on voriconazole trough concentrations in children

artículo científico publicado en 2016

Therapeutic Drug Monitoring of Posaconazole: an Update

artículo científico publicado en 2016

Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment

artículo científico publicado en 2015

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients

artículo científico publicado en 2016

Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care

artículo científico publicado en 2016

Voriconazole metabolism is influenced by severe inflammation: a prospective study

artículo científico publicado en 2016

Lista de obras de

Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future.

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

Bioavailability of voriconazole in hospitalised patients.

Clarithromycin significantly increases linezolid serum concentrations

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents

Clinical validation of the analysis of fluconazole in oral fluid in hospitalized children

Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients

Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill

Dosing ethambutol in obese patients.

Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.

Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis

Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis

Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting.

Ganciclovir Therapeutic Drug Monitoring: A Case Series

Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

Inflammation is associated with voriconazole trough concentrations.

Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis

Limited-sampling strategies for anidulafungin in critically ill patients

Low Caspofungin Exposure in Patients in Intensive Care Units.

Low but sufficient anidulafungin exposure in critically ill patients

Membrane Filtration Is Suitable for Reliable Elimination of Mycobacterium tuberculosis from Saliva for Therapeutic Drug Monitoring

Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework

Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy

Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis

Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis

Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.

Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients

Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

Precision Therapy for Invasive Fungal Diseases

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

Quantification of co-trimoxazole in serum and plasma using MS/MS.

Risk factors contributing to a low darunavir plasma concentration.

Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.

Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis

Statin Adjunctive Therapy for Tuberculosis Treatment

Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis

The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.

The effect of inflammation on voriconazole trough concentrations in children

Therapeutic Drug Monitoring of Posaconazole: an Update

Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients

Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care

Voriconazole metabolism is influenced by severe inflammation: a prospective study